CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - 3 months ended Mar. 31, 2023 - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Capital Surplus	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Unvested Restricted Stock	Vested Restricted Stock Units
Beginning balance (in shares) at Dec. 31, 2022		0	8,706,920
Beginning balance at Dec. 31, 2022	$ 181,719	$ 0	$ 43,714	$ 76,785	$ 73,764	$ (11,048)	$ (477)	$ (1,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	7,671				7,671
Exercise of common stock options (in shares)			20,000
Exercise of common stock options	200		$ 100	100
Issuance of restricted stock (in shares)			20,843
Issuance of restricted stock	0		$ 104	519			(623)
Repurchase of common stock under the stock repurchase program (in shares)			(24,000)
Repurchase of common stock under the stock repurchase program	(575)		$ (120)	(455)
Stock-based compensation	239			104			135
Common stock dividends	(793)				(793)
Other comprehensive income	1,202					1,202
Ending balance (in shares) at Mar. 31, 2023		0	8,723,763
Ending balance at Mar. 31, 2023	$ 189,663	$ 0	$ 43,798	$ 77,053	$ 80,642	$ (9,846)	$ (965)	$ (1,019)